-transparent.png){kind=logo}
The results from this double-blind, multi-investigator study showed that a combination of 50 mg triamterene plus 25 mg hydrochlorothiazide and a combination of 25 mg spironolactone plus 25 mg hydrochlorothiazide were equally efficacious in lowering blood pressure in hypertensive outpatients, and that they produced the same type and incidence of adverse effects. Likewise, the two drug combinations produced similar effects on blood chemistry and hematology. There were no significant differences between the two combination drugs in efficacy laboratory studies, or adverse effects.
Related Publications
T B Cocke, and
S Fisch, and
H R Gilmore, and
R Okun, and
I G Tamagna, and
K Wipplinger
February 1974,
JAMA,
T B Cocke, and
S Fisch, and
H R Gilmore, and
R Okun, and
I G Tamagna, and
K Wipplinger
July 1979,
Southern medical journal,
T B Cocke, and
S Fisch, and
H R Gilmore, and
R Okun, and
I G Tamagna, and
K Wipplinger
October 1963,
JAMA,
T B Cocke, and
S Fisch, and
H R Gilmore, and
R Okun, and
I G Tamagna, and
K Wipplinger
December 1966,
JAMA,
T B Cocke, and
S Fisch, and
H R Gilmore, and
R Okun, and
I G Tamagna, and
K Wipplinger
June 1982,
International journal of clinical pharmacology, therapy, and toxicology,
T B Cocke, and
S Fisch, and
H R Gilmore, and
R Okun, and
I G Tamagna, and
K Wipplinger
November 1969,
Canadian Medical Association journal,
T B Cocke, and
S Fisch, and
H R Gilmore, and
R Okun, and
I G Tamagna, and
K Wipplinger
January 1985,
Clinical therapeutics,
T B Cocke, and
S Fisch, and
H R Gilmore, and
R Okun, and
I G Tamagna, and
K Wipplinger
January 1979,
Clinical pharmacology and therapeutics,
T B Cocke, and
S Fisch, and
H R Gilmore, and
R Okun, and
I G Tamagna, and
K Wipplinger
May 1984,
The British journal of clinical practice,
T B Cocke, and
S Fisch, and
H R Gilmore, and
R Okun, and
I G Tamagna, and
K Wipplinger
December 1987,
European heart journal,
